ALEXANDER BLANK: Open Payments
NPI 1356961015 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,039 in 133 payments from 15 companies in 2025. Trend: 2023 $3,031 · 2024 $2,239 · 2025 $9,039
Consulting: $3,897Food & beverage: $3,819Travel & lodging: $1,196Education: $127
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 26 | $4,642 |
| Janssen Biotech, Inc. | 31 | $1,775 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $528 |
| ABBVIE INC. | 22 | $456 |
| GENZYME CORPORATION | 5 | $408 |
| Arcutis Biotherapeutics, Inc. | 6 | $262 |
| Botanix SB Inc | 7 | $222 |
| Organon LLC | 11 | $193 |
| Galderma Laboratories, L.P. | 4 | $180 |
| UCB, Inc. | 3 | $120 |
Products named: DUPIXENT, TREMFYA, ILUMYA, Zoryve, RINVOQ, SOFDRA, SKYRIZI, NEMLUVIO.
Industry payments across IL — which companies pay providers there.
